FMTX
Income statement / Annual
Last year (2021), Forma Therapeutics Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2021, Forma Therapeutics Holdings, Inc.'s net income was -$172.96 M.
See Forma Therapeutics Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$100.56 M |
$164.09 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$100.56 M
|
$164.09 M
|
| Gross Profit Ratio |
0
|
0
|
1
|
1
|
| Research and Development Expenses |
$125.66 M
|
$93.37 M
|
$111.32 M
|
$132.86 M
|
| General & Administrative Expenses |
$48.33 M
|
$30.78 M
|
$24.40 M
|
$21.54 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$48.33 M
|
$30.78 M
|
$24.40 M
|
$21.54 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$173.99 M
|
$124.15 M
|
$135.72 M
|
$154.40 M
|
| Cost And Expenses |
$173.99 M
|
$124.15 M
|
$135.72 M
|
$154.40 M
|
| Interest Income |
$1.05 M
|
$3.43 M
|
$2.85 M
|
$3.69 M
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.57 M
|
$1.28 M
|
$2.67 M
|
$3.53 M
|
| EBITDA |
-$171.24 M |
-$98.86 M |
-$33.97 M |
$17.39 M |
| EBITDA Ratio |
0
|
0
|
-0.34
|
0.11
|
| Operating Income Ratio |
0
|
0
|
-0.4
|
0.06
|
| Total Other Income/Expenses Net |
$172.96 M
|
$24.08 M
|
$3.81 M
|
$4.17 M
|
| Income Before Tax |
-$172.81 M
|
-$100.13 M
|
-$36.64 M
|
$13.86 M
|
| Income Before Tax Ratio |
0
|
0
|
-0.36
|
0.08
|
| Income Tax Expense |
$154.00 K
|
-$29.72 M
|
-$1.85 M
|
$8.57 M
|
| Net Income |
-$172.96 M
|
-$70.41 M
|
-$34.79 M
|
$5.29 M
|
| Net Income Ratio |
0
|
0
|
-0.35
|
0.03
|
| EPS |
-4.21 |
-3.05 |
-3.06 |
0.47 |
| EPS Diluted |
-4.21 |
-3.05 |
-3.06 |
0.47 |
| Weighted Average Shares Out |
$41.09 M
|
$23.06 M
|
$11.37 M
|
$11.37 M
|
| Weighted Average Shares Out Diluted |
$41.09 M
|
$23.06 M
|
$11.37 M
|
$11.37 M
|
| Link |
|
|
|
|
